🇺🇸 FDA
Patent

US 10154992

Compounds and methods for treating HIV infection

granted A61KA61K31/4365A61K31/444

Quick answer

US patent 10154992 (Compounds and methods for treating HIV infection) held by The Regents of the University of California expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4365, A61K31/444, A61K31/4545, A61K31/496